Professor Tim Key
- A DPhil in Cancer Epidemiology: aetiological investigations of lifestyle, biochemical and molecular factors (CRUK funded project)
- Cancer Epidemiology Unit (CEU)
- Diet and risk of site-specific cancers in the Million Women Study: prospective research including 800,000 women CRUK DPHIL SCHOLARSHIPS AVAILABLE
- Prostate cancer epidemiology
- Proteomics and prostate cancer: Assessing the role of inflammation in the development of aggressive prostate cancer - CRUK DPHIL SCHOLARSHIPS AVAILABLE
- The molecular epidemiology of prostate cancer
BVM&S, MSc, DPhil
Professor of Epidemiology & Deputy Director, CEU
- Cancer Epidemiology Unit
- MSc in Global Health Science module 9 lead: Nutritional Epidemiology
Tim Key has worked as a cancer epidemiologist at the University of Oxford since 1985. His main interests are the roles of diet and hormones in the aetiology of cancer, particularly cancers of the breast, prostate and colon, and the health status of vegetarians and vegans. He currently works mostly on the European Prospective Investigation into Cancer and Nutrition (EPIC), as the principal investigator of the Oxford cohort of 60,000 subjects, including 30,000 people who don’t eat meat. He is also chairman of the EPIC prostate cancer group, co-ordinates the Endogenous Hormones and Breast Cancer Collaborative Group, and is a member of the UK Department of Health’s Scientific Advisory Committee on Nutrition.
Diet, nutrition, and cancer risk: what do we know and what is the way forward?
Key TJ. et al, (2020), BMJ, 368
Physical activity and breast cancer risk: results from the UK Biobank prospective cohort.
Guo W. et al, (2020), Br J Cancer, 122, 726 - 732
Autoimmunity plays a role in the onset of diabetes after 40 years of age.
Rolandsson O. et al, (2020), Diabetologia, 63, 266 - 277
Nutrient-wide association study of 92 foods and nutrients and breast cancer risk.
Heath AK. et al, (2020), Breast Cancer Res, 22
Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study.
Tong TYN. et al, (2019), BMJ, 366